Scott M. Rocklage is a managing partner at 5AM Ventures, a firm that is centered on creating the next generation life science enterprises that can provide exceptional returns to their clients. He joined the company back in 2003 then later became a managing partner in the subsequent year.
Dr. Rocklage has amassed close to 30 years’ worth of experience in the field of Strategic Leadership Responsibilities. This experience is what piloted the approval of three American produced drugs by the Food and Drug Administration Agency (FDN).
These medications include; Omniscan Teslascan and Cubicin which have all been patented in the United States.
Dr, Rocklage has worked in the position of Chairman and CEO of Cubist Pharmaceuticals. He then served as the president and CEO of Nycomed Salutar, at this organization, he got the chance to head the research and development department.
Dr. Rocklage also got the chance to serve as the board executive of Relypsa and Novira, companies that are listed on NASDAQ. As of now, he serves on the board of Rennovia Kinestral not forgetting Cidara (all listed on NASDAQ) in the position of chairman.
Scott Rocklage studied at the University of California where he graduated with a Bachelor of science degree. He later obtained his doctorate from Massachusetts Institute of Technology where he carried out various research programs in Richard Schrock’s Laboratory. Schrock won a Nobel Prize in Chemistry back in 2005.
Scott M Rocklage has been a visionary in the medical field, and this is evident by the 30 plus United States patents he is the inventor or co-inventor.
He has also contributed to the medical and pharmaceutical industry with more than 100 publications reviewed by his peers that he has made over the years.
Even past his prime years, Scott has been keeping up with current social media trends to keep in touch and had a WordPress blog that he posts to regularly.
As an Entrepreneur, He recently interviewed with Ideamensch, during this interview, he revealed that time management and prioritization of tasks are the only ways individuals can take control of their future. During the interview, he encouraged entrepreneurs never to shy from taking calculated risks.
Read more: Scott Racklage | Bloomberg